EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

C1-esterase Inhibitor Treatment is Associated with Immune and Vascular Pathway Modulation in PASC with Neurological Symptoms: Longitudinal Plasma Proteomics

Noga Orr, Maureen Collins, Shawn Novak, Isaac Melamed, Lawrence Steinman

Cellular and Molecular Neurobiology · 19.05.2026 · 46 (1)

DOI: 10.1007/s10571-026-01736-4 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Cellular and Molecular Neurobiology, online erschienen am 19.05.2026. Verfasst von Noga Orr und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA. ornoga@gmail.com. Hauptthemen laut MEDLINE: Complement C1 Inhibitor Protein, COVID-19, COVID-19 Drug Treatment, Nervous System Diseases. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pharming Healthcare Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complement C1 Inhibitor ProteinCOVID-19COVID-19 Drug TreatmentNervous System DiseasesProteomicsAdultFemaleHumansMaleMiddle AgedCross-Over StudiesDouble-Blind MethodLongitudinal StudiesPost-Acute COVID-19 SyndromeSARS-CoV-2

Stichwörter der Autor:innen

C1-INHInflammationNeuroimmune homeostasisPlasma proteomicsPost-acute sequelae of SARS-CoV-2 infection (PASC)Randomized trial

Substanzen

Complement C1 Inhibitor Protein

Autor:innen und Institutionen

  • Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA. ornoga@gmail.com.
  • IMMUNOe Research Center, Centennial, CO, USA.
  • Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
  • Institute for Immunity, Transplantation, and Infection, Stanford University, 269 Campus Drive, Stanford, CA, 94305, USA.

Förderung

  • Pharming Healthcare Inc.

Zitieren

APA

Orr, N., Collins, M., Novak, S., Melamed, I., & Steinman, L. (2026). C1-esterase Inhibitor Treatment is Associated with Immune and Vascular Pathway Modulation in PASC with Neurological Symptoms: Longitudinal Plasma Proteomics. Cellular and Molecular Neurobiology, 46(1). https://doi.org/10.1007/s10571-026-01736-4

Vancouver

Orr N, Collins M, Novak S, Melamed I, Steinman L. C1-esterase Inhibitor Treatment is Associated with Immune and Vascular Pathway Modulation in PASC with Neurological Symptoms: Longitudinal Plasma Proteomics. Cellular and Molecular Neurobiology. 2026;46(1). doi:10.1007/s10571-026-01736-4

BibTeX
@article{Orr2026,
  author = {Orr, Noga and Collins, Maureen and Novak, Shawn and Melamed, Isaac and Steinman, Lawrence},
  title = {C1-esterase Inhibitor Treatment is Associated with Immune and Vascular Pathway Modulation in PASC with Neurological Symptoms: Longitudinal Plasma Proteomics},
  journal = {Cellular and Molecular Neurobiology},
  year = {2026},
  volume = {46},
  number = {1},
  doi = {10.1007/s10571-026-01736-4}
}
Kostenlos starten →